Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design.
Fizazi K, Foulon S, Carles J, Roubaud G, McDermott R, Fléchon A, Tombal B, Supiot S, Berthold D, Ronchin P, Kacso G, Gravis G, Calabro F, Berdah JF, Hasbini A, Silva M, Thiery-Vuillemin A, Latorzeff I, Mourey L, Laguerre B, Abadie-Lacourtoisie S, Martin E, El Kouri C, Escande A, Rosello A, Magne N, Schlurmann F, Priou F, Chand-Fouche ME, Freixa SV, Jamaluddin M, Rieger I, Bossi A; PEACE-1 investigators. Fizazi K, et al. Among authors: chand fouche me. Lancet. 2022 Apr 30;399(10336):1695-1707. doi: 10.1016/S0140-6736(22)00367-1. Epub 2022 Apr 8. Lancet. 2022. PMID: 35405085 Clinical Trial.
Feasibility and early toxicity of intraoperative radiotherapy for breast cancer using the papillon + system: First results.
Chand-Fouché ME, Colnard C, Gal J, Lam Cham Kee D, Dejean C, Gautier M, Feuillade J, Mana A, Fouché Y, Delpech Y, Dejode M, Gérard JP, Barranger E. Chand-Fouché ME, et al. Clin Transl Radiat Oncol. 2022 Oct 21;38:47-52. doi: 10.1016/j.ctro.2022.10.006. eCollection 2023 Jan. Clin Transl Radiat Oncol. 2022. PMID: 36353651 Free PMC article.
High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes.
le Guyader M, Lam Cham Kee D, Thamphya B, Schiappa R, Gautier M, Chand-Fouche ME, Hannoun-Levi JM. le Guyader M, et al. Among authors: chand fouche me. Clin Transl Radiat Oncol. 2021 Nov 6;32:15-23. doi: 10.1016/j.ctro.2021.10.005. eCollection 2022 Jan. Clin Transl Radiat Oncol. 2021. PMID: 34816022 Free PMC article.
High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort.
Marotte D, Gal J, Schiappa R, Gautier M, Boulahssass R, Chand-Fouche ME, Hannoun-Levi JM. Marotte D, et al. Among authors: chand fouche me. Clin Transl Radiat Oncol. 2022 May 21;35:104-109. doi: 10.1016/j.ctro.2022.05.001. eCollection 2022 Jul. Clin Transl Radiat Oncol. 2022. PMID: 35692263 Free PMC article.
13 results